A new poll of Americans shows that 1% of people who get the jab (2M Americans over 18) are so seriously COVID vaccine injured that they are unable to hold a job. Authors: Steve Kirsch Jun 20, 2022 Executive summary The CDC has always maintained that severe reactions to the COVID vaccines are rare. Since I […]
Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California San Diego. In fact, scientists say most coronavirus long-haulers battle brain-related issues. The findings are part of a long-term study tracking the progression of neurological […]
Authors: David Axe June 20, 2022 TDB COVID-19 cases are increasing again in the United Kingdom, potentially signaling a future surge in infections in the United States and other countries. A pair of new subvariants of the dominant Omicron variant—BA.4 and BA.5—appear to be driving the uptick in cases in the U.K. Worryingly, these subvariants seem […]
‘It’s an unpredictable and unstable situation,’ says immune system expert Prof. Cyrille Cohen, urging lawmakers to ‘actively encourage herd immunity among the vulnerable’ Authors: Times of Israel June 2022 The number of coronavirus patients in serious condition in Israel reached 140 on Friday, marking a near 70% rise since last week, with health experts warning […]
Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573. Apr 27. 2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of clinical manifestations, with progression to multiorgan failure in the most severe cases. Several biomarkers can be altered […]
Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]
Authors: Jim Hoft Published June 16, 2022 The Gateway Pundit A 40-year-old father from British Columbia was one of the first people in Canada to be compensated after suffering an adverse reaction connected to the COVID-19 vaccine. Ross Wightman, a former pilot and realtor was diagnosed with Guillain-Barré Syndrome (GBS), which is a rare disorder in […]
Authors: Damian D. Guerra, Daniel J. Guerra doi: https://doi.org/10.1101/2021.05.18.21257385 Abstract Background Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission. Because COVID-19 can spread via respired droplets, many states have mandated mask use in public settings. Randomized control trials have not clearly demonstrated mask efficacy against respiratory viruses, and observational studies conflict on whether mask use predicts lower […]
Authors: Robert Verkerk PhD1, Christof Plothe DO2, Naseeba Kathrada MBChB3 andKatarina Lindley DO4, Science Unit, Alliance for Natural Health International, 78 Dorking Road, Chilworth, Surrey, GU4 8NS, United Kingdom, Praxis für Biophysikalische Osteopathie, Am Wegweiser Alzey, Germany, Dr Kats, 86 Jan Hofmeyer Road, Dawncrest, Westville, 3629, South Africa, Lindley Medical, 2100 FM 1189, Brock, Texas […]
